|
|
Article: Lannett Company Names Stephen J. Kovary Vice President Operations.
- Article from:
- Biotech Week
- Article date:
- September 23, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, announced the appointment of Stephen J. Kovary as vice president - operations, succeeding Bernard Sandiford who retired. Kovary will report to Arthur Bedrosian, president and chief executive officer of Lannett (see also Lannett Company, Inc.).
"Stephen brings extensive operations, plant management and manufacturing experience," said Bedrosian. "He's a veteran of the pharmaceutical industry, having held senior management positions with some of the largest and best known pharmaceutical companies in the world. We welcome him to the Lannett family and look forward to benefiting from ...
Related newspaper, magazine, and journal articles:
|
|
Article: Lannett Company Inc. vs. the Global Market.
M2 Presswire;
February 28, 2007 ;
700+ words
... ... 2007-www.streetinvesting.com: Lannett Company Inc. vs. the Global Market(C ... dismal performance, investors of Lannett Company Inc. (AMEX:LCI) were subject ... throughout the American Markets. Lannett Company Inc. was one of the prospective companies ...
|
|